Royalty Pharma RPRX
NASDAQ RPRX
$61.76 +1.49 (+2.47%)
As of: Oct 20, 2026 · 11:01 AM EDT

Royalty Pharma plc (RPRX) EV to EBIT (2020 - 2026)

Updated

Royalty Pharma's (RPRX) EV to EBIT was 22.73 for Q2 2026, up 77.8% from 12.78 a year earlier and up 20.0% from the prior quarter.

Analysis

Royalty Pharma plc (RPRX) EV to EBIT (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Royalty Pharma's EV to EBIT came in at 21.27, up 91.6% year-over-year; for FY2025, it came in at 15.97, up 18.3% from FY2024.

  • By year, EV to EBIT came in at 13.49 in FY2024 (+1.4%), 13.30 in FY2023 (-84.4%), 85.19 in FY2022 (+359.2%) and 18.55 in FY2021 (-11.6%).
  • The Q2 2026 figure ranks as the highest quarterly EV to EBIT since Q3 2023.
  • Year over year, EV to EBIT has now increased in each of the last four quarters, with growth averaging 5.7% over the last eight quarters.
  • The high point for year-over-year EV to EBIT in five years was Q4 2022 (growth of 359.2%); the low point was Q4 2023 (a decline of 84.4%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 18.94 (Q1 2026), 15.97 (Q4 2025) and 14.80 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.73
Mar 31, 2026 18.94
Dec 31, 2025 15.97
Sep 30, 2025 14.80
Jun 30, 2025 12.78
Mar 31, 2025 10.33
Dec 31, 2024 13.49
Sep 30, 2024 12.34
Jun 30, 2024 17.86
Mar 31, 2024 21.97
Dec 31, 2023 13.30
Sep 30, 2023 47.26
Jun 30, 2023 45.39
Mar 31, 2023 41.97
Dec 31, 2022 85.19
Sep 30, 2022 28.91
Jun 30, 2022 26.03
Mar 31, 2022 18.12
Dec 31, 2021 18.55
Sep 30, 2021 15.39
API Access

Royalty Pharma plc EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=RPRX&period=max&api_key=YOUR_API_KEY